EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome

Jiao Tang, Zhehao Xu, Li Ren, Jiahua Xu, Xin Chen, Yian Jin, Ruiyun Liang, Huanji Zhang

Lipids in Health and Disease · 18.12.2024 · 23 (1)

DOI: 10.1186/s12944-024-02400-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lipids in Health and Disease, online erschienen am 18.12.2024. Verfasst von Jiao Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Klotho Proteins, Metabolic Syndrome, Glucuronidase. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is characterized as a systemic disease resulting from the pathophysiological interplay among metabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD). The Klotho protein may serve as a novel biomarker. However, the utility of serum Klotho levels as an indicator of severity and mortality risk in CKM syndrome remains uncertain. METHODS: This study involved 9,871 participants from the National Health and Nutrition Examination Survey (NHANES) conducted between 2007 and 2016. Serum Klotho levels were measured using an enzyme-linked immunosorbent assay kit. The optimal cutoff value was established through the maximum Youden's index. Multivariable weighted regression models were employed to calculate the odds ratio and hazard ratio, along with the 95% confidence interval, to evaluate the association between serum Klotho levels and the severity of CKM syndrome, as well as all-cause and cardiovascular mortality. Additionally, the receiver operating characteristic curve and restricted cubic spline curves were utilized to assess predictive efficacy and to explore nonlinear relationships. RESULTS: After adjusting for potential confounding factors, a non-linear relationship was seen between the Klotho protein, and CKM syndrome. In the multivariable, piecewise logistic regression, when the Serum klotho was less than 801, the risk of CKM syndrome decreased with the increase in Serum klotho (OR = 0.82, 95%CI 0.70, 0.96; p < 0.001). Furthermore, we observed the association when the Serum klotho was greater than 801 (OR = 0.94, 95%CI 0.89, 0.99; p = 0.035). The relationship between serum Klotho levels and all-cause mortality was U-shaped, while the relationship with cardiovascular mortality was L-shaped. Specifically, low serum Klotho levels were associated with an increase in all-cause mortality by 21% and cardiovascular mortality by 76% among patients with CKM syndrome. Furthermore, serum Klotho levels demonstrated excellent predictive efficacy for both the severity and mortality associated with CKM syndrome. CONCLUSIONS: This study indicates that low serum Klotho levels serve as reliable indicators of both the severity of CKM syndrome and the associated risk of mortality. HIGHLIGHTS: This study is the first to reveal the relationship between serum Klotho levels and the severity and mortality of CKM syndrome.Serum Klotho is significantly associated with the severity of CKM syndrome.Serum Klotho was U-shaped related to all-cause mortality in patients with CKM syndrome.Serum Klotho was L-shaped associated with cardiovascular mortality in patients with CKM syndrome stage 0–3.Low serum Klotho level is an independent risk factor for the progression of CKM syndrome as well as all-cause and cardiovascular mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klotho ProteinsMetabolic SyndromeGlucuronidaseHumansMaleFemaleMiddle AgedAdultCardiovascular DiseasesBiomarkersRisk FactorsRenal Insufficiency, ChronicAgedROC CurveNutrition SurveysCardio-Renal SyndromeSeverity of Illness IndexOdds Ratio

Stichwörter der Autor:innen

Cardiovascular-kidney-metabolic syndromeKlothosMetabolic syndromeNHANES

Substanzen

Klotho ProteinsGlucuronidaseBiomarkersKL protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Department of General Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Respiratory Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Cardiovascular Medicine, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. zhanghj65@mail.sysu.edu.cn.

Zitieren

APA

Tang, J., Xu, Z., Ren, L., Xu, J., Chen, X., Jin, Y., Liang, R., & Zhang, H. (2024). Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome. Lipids in Health and Disease, 23(1). https://doi.org/10.1186/s12944-024-02400-w

Vancouver

Tang J, Xu Z, Ren L, Xu J, Chen X, Jin Y, et al. Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome. Lipids in Health and Disease. 2024;23(1). doi:10.1186/s12944-024-02400-w

BibTeX
@article{Tang2024,
  author = {Tang, Jiao and Xu, Zhehao and Ren, Li and Xu, Jiahua and Chen, Xin and Jin, Yian and Liang, Ruiyun and Zhang, Huanji},
  title = {Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome},
  journal = {Lipids in Health and Disease},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.1186/s12944-024-02400-w}
}
Kostenlos starten →